{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:35:13Z","timestamp":1780360513765,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00432-023-04868-y","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T17:01:48Z","timestamp":1685206908000},"page":"9721-9726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Involvement of spleen is associated with shorter survival in patients with angioimmunoblastic T cell lymphoma"],"prefix":"10.1007","volume":"149","author":[{"given":"Yingdan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"issue":"3","key":"4868_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.2020010387","volume":"138","author":"RH Advani","year":"2021","unstructured":"Advani RH, Skrypets T, Civallero M, Spinner MA, Manni M, Kim WS, Shustov AR, Horwitz SM, Hitz F, Cabrera ME et al (2021) Outcomes and prognostic factors in angioimmunoblastic T cell lymphoma: final report from the international T cell Project. Blood 138(3):213\u2013220","journal-title":"Blood"},{"issue":"9","key":"4868_CR2","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1182\/bloodadvances.2021006715","volume":"6","author":"A Al Zaki","year":"2022","unstructured":"Al Zaki A, Feng L, Watson G, Ahmed SA, Mistry H, Nastoupil LJ, Hawkins M, Nair R, Iyer SP, Lee HJ et al (2022) Day 30 SUVmax predicts progression in patients with lymphoma achieving PR\/SD after CAR T cell therapy. Blood Adv 6(9):2867\u20132871","journal-title":"Blood Adv"},{"issue":"15","key":"4868_CR3","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.3390\/cancers14153814","volume":"14","author":"D Albano","year":"2022","unstructured":"Albano D, Dondi F, Bertagna F, Treglia G (2022) The role of [(68)Ga]Ga-pentixafor PET\/CT or PET\/MRI in lymphoma: a systematic review. Cancers (basel) 14(15):3814","journal-title":"Cancers (basel)"},{"issue":"1","key":"4868_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5581\/1516-8484.20120013","volume":"34","author":"M Bellei","year":"2012","unstructured":"Bellei M, Chiattone CS, Luminari S, Pesce EA, Cabrera ME, de Souza CA, Gabus R, Zoppegno L, Zoppegno L, Milone J et al (2012) T cell lymphomas in South America and Europe. Rev Bras Hematol Hemoter 34(1):42\u201347","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"5","key":"4868_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/01926230600867743","volume":"34","author":"MF Cesta","year":"2006","unstructured":"Cesta MF (2006) Normal structure, function, and histology of the spleen. Toxicol Pathol 34(5):455\u2013465","journal-title":"Toxicol Pathol"},{"issue":"10","key":"4868_CR6","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba S, Sakata-Yanagimoto M (2020) Advances in understanding of angioimmunoblastic T cell lymphoma. Leukemia 34(10):2592\u20132606","journal-title":"Leukemia"},{"issue":"2","key":"4868_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/cam4.2742","volume":"9","author":"AE Eladl","year":"2020","unstructured":"Eladl AE, Shimada K, Suzuki Y, Takahara T, Kato S, Kohno K, Elsayed AA, Wu CC, Tokunaga T, Kinoshita T et al (2020) EBV status has prognostic implication among young patients with angioimmunoblastic T cell lymphoma. Cancer Med 9(2):678\u2013688","journal-title":"Cancer Med"},{"issue":"2","key":"4868_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage KJ et al (2013) Clinicopathologic characteristics of angioimmunoblastic T cell lymphoma: analysis of the international peripheral T cell lymphoma project. J Clin Oncol 31(2):240\u2013246","journal-title":"J Clin Oncol"},{"issue":"3","key":"4868_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.semdp.2011.03.003","volume":"28","author":"P Gaulard","year":"2011","unstructured":"Gaulard P, de Leval L (2011) Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol 28(3):202\u2013213","journal-title":"Semin Diagn Pathol"},{"issue":"19","key":"4868_CR10","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, Greiner TC, Smith L, Guo S, Wilcox RA et al (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T cell lymphoma. Blood 123(19):2915\u20132923","journal-title":"Blood"},{"issue":"1","key":"4868_CR11","first-page":"136","volume":"30","author":"J Li","year":"2022","unstructured":"Li J, Zhao M, Yuan L, Liu Y, Ma N (2022) Correlation and influencing factors of SUVmax and Ki-67 in non-Hodgkin lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 30(1):136\u2013140","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"9","key":"4868_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","volume":"129","author":"MA Lunning","year":"2017","unstructured":"Lunning MA, Vose JM (2017) Angioimmunoblastic T cell lymphoma: the many-faced lymphoma. Blood 129(9):1095\u20131102","journal-title":"Blood"},{"issue":"9","key":"4868_CR13","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Briere J, Raffoux E, Delmer A, Feller A, Meijer CJ, Emile JF, Bouabdallah R, Bosly A et al (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials. Blood 111(9):4463\u20134470","journal-title":"Blood"},{"issue":"22","key":"4868_CR14","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S, Gazzola A, Gloghini A, Righi S, Rossi M et al (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 67(22):10703\u201310710","journal-title":"Cancer Res"},{"issue":"1","key":"4868_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3324\/haematol.2020.263194","volume":"107","author":"C Rossi","year":"2022","unstructured":"Rossi C, Tosolini M, Gravelle P, Pericart S, Kanoun S, Evrard S, Gilhodes J, Franchini DM, Amara N, Syrykh C et al (2022) Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. Haematologica 107(1):221\u2013230","journal-title":"Haematologica"},{"issue":"4","key":"4868_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11864-006-0036-3","volume":"7","author":"P Solal-Celigny","year":"2006","unstructured":"Solal-Celigny P (2006) Follicular lymphoma international prognostic index. Curr Treat Options Oncol 7(4):270\u2013275","journal-title":"Curr Treat Options Oncol"},{"issue":"7","key":"4868_CR17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ajh.25493","volume":"94","author":"F St-Pierre","year":"2019","unstructured":"St-Pierre F, Broski SM, LaPlant BR, Ristow K, Maurer MJ, Macon WR, Habermann TM, Ansell SM, Thompson CA, Micallef INM et al (2019) Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma. Am J Hematol 94(7):786\u2013793","journal-title":"Am J Hematol"},{"issue":"17","key":"4868_CR18","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1002\/cncr.27381","volume":"118","author":"H Takahashi","year":"2012","unstructured":"Takahashi H, Tomita N, Yokoyama M, Tsunoda S, Yano T, Murayama K, Hashimoto C, Tamura K, Sato K, Ishigatsubo Y (2012) Prognostic impact of extranodal involvement in diffuse large B cell lymphoma in the rituximab era. Cancer 118(17):4166\u20134172","journal-title":"Cancer"},{"issue":"1","key":"4868_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bjh.16428","volume":"189","author":"MA Timmins","year":"2020","unstructured":"Timmins MA, Wagner SD, Ahearne MJ (2020) The new biology of PTCL-NOS and AITL: current status and future clinical impact. Br J Haematol 189(1):54\u201366","journal-title":"Br J Haematol"},{"issue":"25","key":"4868_CR20","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T cell and natural killer\/T cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol"},{"key":"4868_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109793","volume":"141","author":"L Zanoni","year":"2021","unstructured":"Zanoni L, Mattana F, Calabro D, Paccagnella A, Broccoli A, Nanni C, Fanti S (2021) Overview and recent advances in PET\/CT imaging in lymphoma and multiple myeloma. Eur J Radiol 141:109793","journal-title":"Eur J Radiol"},{"issue":"5","key":"4868_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1080\/10428194.2021.2015586","volume":"63","author":"C Zhang","year":"2022","unstructured":"Zhang C, Mi L, Wu M, Liu W, Ma H, Ren J, Zhao L, Wang X, Song Y, Zhu J (2022) Angioimmunoblastic T cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China. Leuk Lymphoma 63(5):1152\u20131159","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04868-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T05:58:48Z","timestamp":1702533528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04868-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4868"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04868-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,27]]},"assertion":[{"value":"14 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}